Evaluation of bedside prothrombin time and activated partial thromboplastin time measurement by coagulation analyzer CoaguCheck Plus in various clinical settings

Thromb Res. 1997 Sep 1;87(5):431-40. doi: 10.1016/s0049-3848(97)00159-x.

Abstract

In the present study CoaguCheck Plus (CCP), a coagulation test system using whole blood, was evaluated with respect to its comparability with widely distributed conventional routine coagulation assays. A correlation of r = 0.997 (p < 0.0001) was found between INR of CCP-prothrombin time (CCP-PT) and Thrombotest (KC-1 analyzer) in patients on oral anticoagulant therapy. A correlation of r = 0.899 (p < 0.001) between CCP-aPTT and Actin ES aPTT (STA analyzer) was found in heparinized patients. Impaired hepatic hepatic coagulation factor synthesis in liver cirrhosis patients was detected by CCP-PT with a sensitivity of 0.75 and by Normotest (STA analyzer) with a sensitivity of 0.92. Those patients with normal CCP-PT values and liver disease had, only mild reductions (> 30% of normals) in coagulation factors II, V, VII or X. CCP-aPTT was also performed in patients with a deficiency in the so called endogenous coagulation factors VIII, IX, XI and XII. CCP-aPTT showed a sensitivity similar to that of Actin FS aPTT in the detection even of mild deficiencies in factors VIII, IX and XII; factor XI deficiency was however detected only in patients with severe (< 12% of normals) disease; lupus anticoagulants were detected with a high sensitivity.

MeSH terms

  • Blood Coagulation Tests / instrumentation*
  • Heparin / therapeutic use
  • Humans
  • Indicators and Reagents
  • Liver Function Tests
  • Lupus Coagulation Inhibitor / analysis
  • Partial Thromboplastin Time
  • Point-of-Care Systems
  • Prothrombin Time*
  • Reference Values
  • Sensitivity and Specificity

Substances

  • Indicators and Reagents
  • Lupus Coagulation Inhibitor
  • Heparin